Antithyroid Drugs-The Most Common Treatment for Graves' Disease in the United States: A Nationwide Population-Based Study

Thyroid. 2016 Aug;26(8):1144-5. doi: 10.1089/thy.2016.0222. Epub 2016 Jul 5.

Authors

Juan P Brito¹, Stephanie Schilz², Naykky Singh Ospina¹, Rene Rodriguez-Gutierrez^{1

3}, Spyridoula Maraka¹, Lindsey R Sangaralingham², Victor M Montori¹

Affiliations

¹ 1 Division of Endocrinology, Diabetes, Metabolism, and Nutrition and Knowledge and Evaluation Research Unit in Endocrinology (KER_Endo), Mayo Clinic , Rochester, Minnesota.
² 2 Mayo Clinic Robert D. and Patricia E. Kern Center for Science of Health Care Delivery , Rochester, Minnesota.
³ 3 Endocrinology Division, Department of Internal Medicine, University Hospital "Dr. Jose E. Gonzalez ," Monterrey, Mexico .

PMID: 27267495
DOI: 10.1089/thy.2016.0222

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
Antithyroid Agents / therapeutic use*
Drug Utilization
Female
Graves Disease / drug therapy*
Graves Disease / epidemiology
Health Care Surveys
Humans
Male
Methimazole / therapeutic use
Middle Aged
United States / epidemiology

Substances

Antithyroid Agents
Methimazole